| Thomas Randall Hines, MD | |
|
25 Medical Dr, Amarillo, TX 79106 | |
| (806) 677-0500 | |
| (806) 677-0860 |
| Full Name | Thomas Randall Hines |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 27 Years |
| Location | 25 Medical Dr, Amarillo, Texas |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336141670 | NPI | - | NPPES |
| 0025LE | Other | TX | BLUE CROSS OF TEXAS |
| 11518101 | Other | TX | FIRST CARE/SW LIFE |
| 164624201 | Medicaid | TX | |
| 200172742 | Other | TX | HUMANA MILITARY |
| 164624202 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | K6469 (Texas) | Primary |
| Entity Name | Privia Medical Group West Texas, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346242567 PECOS PAC ID: 5597747378 Enrollment ID: O20040604000460 |
News Archive
Analyzing the genes expressed by cancer cells allows for a better understanding of that patient's specific disease and in turn, a more personalized approach to treatment. But obtaining the RNA from a tumor in the lungs in order to conduct the genetic analysis is a challenging prospect. Currently, lung cancer researchers are limited to using RNA extracted from early-stage tumors removed during surgery. The small quantities of tissue extracted during routine diagnostic biopsies have not been useful to researchers, due to their small size and the variety of ways they have been processed.
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, today announced positive preliminary results of a Phase IIa study in inflammatory bowel disease (IBD) with its lead autoimmune compound vidofludimus, an oral inhibitor of interleukin-17 (IL-17) release.
Advanced BioMedical Technologies Inc. announced that it has completed all 60 human clinical test cases of its PA Absorbable Orthopaedic Implant Screw according to the regulations set out by the China State Food and Drug Administration (SFDA). The actual number of test cases that have been taken in is 63.
A team of researchers led by scientists at Weill Cornell Medical College has designed what appears to be a powerful gene therapy strategy that can treat both beta-thalassemia disease and sickle cell anemia. They have also developed a test to predict patient response before treatment.
› Verified 7 days ago
| Entity Name | Randy Hines Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326166497 PECOS PAC ID: 7214910983 Enrollment ID: O20040611001382 |
News Archive
Analyzing the genes expressed by cancer cells allows for a better understanding of that patient's specific disease and in turn, a more personalized approach to treatment. But obtaining the RNA from a tumor in the lungs in order to conduct the genetic analysis is a challenging prospect. Currently, lung cancer researchers are limited to using RNA extracted from early-stage tumors removed during surgery. The small quantities of tissue extracted during routine diagnostic biopsies have not been useful to researchers, due to their small size and the variety of ways they have been processed.
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, today announced positive preliminary results of a Phase IIa study in inflammatory bowel disease (IBD) with its lead autoimmune compound vidofludimus, an oral inhibitor of interleukin-17 (IL-17) release.
Advanced BioMedical Technologies Inc. announced that it has completed all 60 human clinical test cases of its PA Absorbable Orthopaedic Implant Screw according to the regulations set out by the China State Food and Drug Administration (SFDA). The actual number of test cases that have been taken in is 63.
A team of researchers led by scientists at Weill Cornell Medical College has designed what appears to be a powerful gene therapy strategy that can treat both beta-thalassemia disease and sickle cell anemia. They have also developed a test to predict patient response before treatment.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Randall Hines, MD 25 Medical Dr, Amarillo, TX 79106-4169 Ph: (806) 677-0500 | Thomas Randall Hines, MD 25 Medical Dr, Amarillo, TX 79106 Ph: (806) 677-0500 |
News Archive
Analyzing the genes expressed by cancer cells allows for a better understanding of that patient's specific disease and in turn, a more personalized approach to treatment. But obtaining the RNA from a tumor in the lungs in order to conduct the genetic analysis is a challenging prospect. Currently, lung cancer researchers are limited to using RNA extracted from early-stage tumors removed during surgery. The small quantities of tissue extracted during routine diagnostic biopsies have not been useful to researchers, due to their small size and the variety of ways they have been processed.
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, today announced positive preliminary results of a Phase IIa study in inflammatory bowel disease (IBD) with its lead autoimmune compound vidofludimus, an oral inhibitor of interleukin-17 (IL-17) release.
Advanced BioMedical Technologies Inc. announced that it has completed all 60 human clinical test cases of its PA Absorbable Orthopaedic Implant Screw according to the regulations set out by the China State Food and Drug Administration (SFDA). The actual number of test cases that have been taken in is 63.
A team of researchers led by scientists at Weill Cornell Medical College has designed what appears to be a powerful gene therapy strategy that can treat both beta-thalassemia disease and sickle cell anemia. They have also developed a test to predict patient response before treatment.
› Verified 7 days ago
Elizabeth Tu, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 S Coulter St Ste 5100, Amarillo, TX 79106 Phone: 806-414-9559 Fax: 806-351-3767 | |
Dr. David Thetford, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 275 Casino Dr, Amarillo, TX 79118 Phone: 806-884-9943 | |
Brian Gillette, MHS, PA-C Family Medicine Medicare: Medicare Enrolled Practice Location: 1100 S Coulter St, Amarillo, TX 79106 Phone: 806-468-9700 | |
Pamela K Banister, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3501 S Soncy Rd Ste 150, Amarillo, TX 79119 Phone: 806-212-6353 Fax: 806-212-0558 | |
Dr. Wesley Scott Nickens, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2701 S Georgia St, Amarillo, TX 79109 Phone: 806-350-8980 Fax: 806-350-7573 | |
Genkai Jason Huang, Family Medicine Medicare: Medicare Enrolled Practice Location: 2701 S Georgia St, Amarillo, TX 79109 Phone: 806-350-8980 Fax: 806-350-7573 | |
Gary J Hilton, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2701 S Georgia St, Amarillo, TX 79109 Phone: 806-350-3000 Fax: 806-350-3337 |